|
Apr 24
|
Colgate-Palmolive earnings, consumer sentiment: What to Watch
|
|
Apr 24
|
AbbVie Submits Biologics License Application to U.S. FDA for TrenibotulinumtoxinE (TrenibotE) for the Treatment of Glabellar Lines
|
|
Apr 10
|
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
|
|
Apr 9
|
Dow Jones, S&P 500 Pharma Names Recover After Trump Backs Off His Tariffs Plan
|
|
Apr 9
|
Novo Nordisk, AbbVie Stocks Slide After Trump Vows Pharma Tariffs
|
|
Apr 8
|
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
|
|
Apr 7
|
AbbVie (NYSE:ABBV) Showcases Cancer Treatment Advancements at AACR Annual Meeting
|
|
Feb 16
|
AbbVie Full Year 2024 Earnings: EPS Misses Expectations
|
|
Feb 14
|
AbbVie Appoints CEO Robert A. Michael as Chairman of the Board of Directors
|
|
Feb 13
|
AbbVie Declares Quarterly Dividend
|
|
Feb 13
|
Is AbbVie Inc. (NYSE:ABBV) Trading At A 47% Discount?
|
|
Feb 12
|
Allergan Aesthetics To Launch Three New State-of-the-Art Training Centers in the U.S. Expanding Access to High Quality Aesthetics Training
|
|
Feb 12
|
AbbVie and Xilio Therapeutics Announce Collaboration and Option Agreement to Develop Novel Tumor-Activated Immunotherapies
|
|
Jan 24
|
Stocks to watch next week: ASML, Intel, LVMH, Shell and Glencore
|
|
Jan 24
|
Allergan Aesthetics unveils new AA Signature Program and immersive booth at IMCAS World Congress 2025
|
|
Jan 23
|
AbbVie Completes Acquisition of Nimble Therapeutics
|
|
Jan 23
|
AbbVie and Neomorph Announce Collaboration to Develop Molecular Glue Degraders for Oncology and Immunology
|
|
Jan 22
|
Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk
|
|
Jan 22
|
AbbVie Insiders Sold US$56m Of Shares Suggesting Hesitancy
|
|
Jan 21
|
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why
|